|
Volumn 10, Issue 4, 2012, Pages 351-353
|
Targeting β-catenin in CML: Leukemia stem cells beware!
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BCR ABL PROTEIN;
BETA CATENIN;
IMATINIB;
INDOMETACIN;
SIRTUIN 1;
WNT PROTEIN;
AUTOPHAGY;
BONE MARROW TRANSPLANTATION;
CANCER PATIENT;
CANCER REGRESSION;
CANCER RELAPSE;
CANCER STEM CELL;
CANCER SURVIVAL;
CELL SURVIVAL;
CHRONIC MYELOID LEUKEMIA;
DRUG EFFICACY;
GENE DELETION;
GENE INACTIVATION;
GENE MUTATION;
HUMAN;
LEUKEMIC STEM CELL;
LEUKOCYTE COUNT;
NONHUMAN;
NOTE;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
SIGNAL TRANSDUCTION;
STEM CELL TRANSPLANTATION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
|
EID: 84859552482
PISSN: 19345909
EISSN: 18759777
Source Type: Journal
DOI: 10.1016/j.stem.2012.03.006 Document Type: Short Survey |
Times cited : (13)
|
References (10)
|